Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease

Inflammatory bowel disease (IBD) is a chronic inflammatory state of the GI tract of unknown etiology. Classically, tissue injury in IBD is thought to be primarily mediated by Th1 cells in Crohn’s disease or Th2 cells in ulcerative colitis. The discoveries of new subsets of T-helper cells, especially Th17 cells, have revolutionized our understanding of the disease immunopathology. Th17 cells seem to affect both innate and adaptive immune responses by the release of regulatory cytokines. Understanding the role of Th17 cells in IBD pathogenesis and targeting their regulatory cytokines may provide potential therapeutic approaches for the treatment of IBD in the future.

[1]  Jung Ok Shim,et al.  Gut Microbiota in Inflammatory Bowel Disease , 2013, Pediatric gastroenterology, hepatology & nutrition.

[2]  D. Ma,et al.  IL-21 and IL-12 Inhibit Differentiation of Treg and TH17 Cells and Enhance Cytotoxicity of Peripheral Blood Mononuclear Cells in Patients With Cervical Cancer , 2011, International Journal of Gynecologic Cancer.

[3]  U. Navaneethan,et al.  The Levels of IL-17 Secreted by Lipopolysaccharide-Stimulated Eripheral Blood Mononuclear Cells (PBMC) in Inflammatory Bowel Disease (IBD) Patients Significantly Correlated with Disease Severity in Ulcerative Colitis but Not in Crohnʼs Disease: 1275 , 2011 .

[4]  D. Klatzmann,et al.  Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. , 2011, The Journal of allergy and clinical immunology.

[5]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[6]  T. Mcclanahan,et al.  Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. , 2011, Immunity.

[7]  Stephen Newland,et al.  Epigenetic Changes at Il12rb2 and Tbx21 in Relation to Plasticity Behavior of Th17 Cells , 2011, The Journal of Immunology.

[8]  C. Lees,et al.  Genetics of ulcerative colitis , 2011, Inflammatory bowel diseases.

[9]  P. Miossec,et al.  Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes , 2011, Annals of the rheumatic diseases.

[10]  Ruifu Yang,et al.  Reciprocal modulation between TH17 and other helper T cell lineages , 2011, Journal of cellular physiology.

[11]  J. O’Shea,et al.  Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. , 2010, Cytokine & growth factor reviews.

[12]  P. Miossec,et al.  IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes , 2010, Annals of the rheumatic diseases.

[13]  Andreas Radbruch,et al.  IFN‐γ and IL‐12 synergize to convert in vivo generated Th17 into Th1/Th17 cells , 2010, European journal of immunology.

[14]  T. Macdonald,et al.  IL‐23/IL‐17 axis in IBD , 2010, Inflammatory bowel diseases.

[15]  R. Sabat,et al.  Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. , 2010, Cytokine & growth factor reviews.

[16]  J. Cosnes.  Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD , 2010, Digestive Diseases.

[17]  V. Kuchroo,et al.  Effector and Regulatory T‐cell Subsets in Autoimmunity and Tissue Inflammation , 2010, Scandinavian journal of immunology.

[18]  Hong Wang,et al.  Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. , 2010, Frontiers in bioscience.

[19]  Nicolas Manel,et al.  Les bactéries filamenteuses segmentées induisent les cellules Th17 dans l'intestin , 2010 .

[20]  M. Raffatellu,et al.  Th17 Cytokines and the Gut Mucosal Barrier , 2010, Journal of Clinical Immunology.

[21]  S. Walsh,et al.  A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland , 2009, Obesity Facts.

[22]  E. Barillot,et al.  Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. , 2009, Blood.

[23]  Annaïg Lan,et al.  The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.

[24]  E. Engleman,et al.  Obesity predisposes to Th17 bias , 2009, European journal of immunology.

[25]  Li V. Yang,et al.  Il‐21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[26]  S. Brand.  Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease , 2009, Gut.

[27]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[28]  黄亚明.  MedScape , 2009 .

[29]  Izortze Santin,et al.  TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin , 2009, Autoimmunity.

[30]  G. Macfarlane,et al.  Intestinal bacteria and inflammatory bowel disease , 2009, Critical reviews in clinical laboratory sciences.

[31]  W. Sandborn,et al.  An Update on the Epidemiology of Inflammatory Bowel Disease in Asia , 2008, The American Journal of Gastroenterology.

[32]  D. Rifkin,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[33]  T. Hibi,et al.  IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease , 2008, Gut.

[34]  T. Hibi,et al.  Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. , 2008, The Journal of clinical investigation.

[35]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[36]  M. McGeachy,et al.  Th17 cell differentiation: the long and winding road. , 2008, Immunity.

[37]  J. O’Shea,et al.  Cytokine signaling modules in inflammatory responses. , 2008, Immunity.

[38]  Wendy S. Garrett,et al.  Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.

[39]  F. Powrie,et al.  The IL23 axis plays a key role in the pathogenesis of IBD , 2007, Gut.

[40]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[41]  Terry B. Strom,et al.  IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.

[42]  S. Reiner.  Development in Motion: Helper T Cells at Work , 2007, Cell.

[43]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[44]  P. Lipsky,et al.  IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1 , 2005, The Journal of Immunology.

[45]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[46]  T. Macdonald,et al.  Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. , 2005, Gastroenterology.

[47]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[48]  M. Kamoun,et al.  Early administration of IL-12 suppresses EAE through induction of interferon-γ , 2004, Journal of Neuroimmunology.

[49]  D. Phil.,et al.  Incidence of Inflammatory Bowel Disease is Rising and Abdominal Tuberculosis is Falling in Bangladeshis in East London, United Kingdom , 2004, American Journal of Gastroenterology.

[50]  I. Julkunen,et al.  IFN‐α regulates IL‐21 and IL‐21R expression in human NK and T cells , 2004 .

[51]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[52]  L. Moretta,et al.  IL‐21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig‐like receptors , 2003, European journal of immunology.

[53]  M. Neurath,et al.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.

[54]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[55]  D. Foster,et al.  IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells1 , 2003, The Journal of Immunology.

[56]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[57]  T. Sakaguchi,et al.  Claudins regulate the intestinal barrier in response to immune mediators. , 2000, Gastroenterology.

[58]  J. Sundberg,et al.  CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease , 1998, The Journal of experimental medicine.

[59]  R. Hammer,et al.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.

[60]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[61]  B. Uitdehaag,et al.  Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon‐gamma in Lewis rats , 1990, Clinical and experimental immunology.

[62]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[63]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[64]  I. Ivanov,et al.  [Induction of gut mucosal Th17 cells by segmented filamentous bacteria]. , 2010, Medecine sciences : M/S.

[65]  S. Brand.  Crohn ’ s disease : Th 1 , Th 17 or both ? The change of a paradigm : new immunological and genetic insights implicate Th 17 cells in the pathogenesis of Crohn ’ s disease , 2009 .

[66]  A. Antsaklis,et al.  Effect of IL-21 on NK cells derived from different umbilical cord blood populations. , 2006, International immunology.

[67]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.